BioLineRx reports positive preclinical data for GLIX1 in brain cancer
Go back to BioLineRx reports positive preclinical data for GLIX1 in brain cancer| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 3.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.24 | 52 Week High | $1.63 | |||
| Open | $3.24 | 52 Week Low | $0.71 | |||
| Day High | $3.24 | P/E | N/A | |||
| Day Low | $3.24 | EPS | $0.00 | |||
| Volume | 10,339 | |||||

